VC Firm Dimension Capital Raises $800M for Its Third Fund
Dimension Capital, a New York-based venture capital firm founded in late 2022, has made a significant stride in the tech industry by announcing its third fund worth $800 million. This substantial investment is 60% larger than its second vehicle, which was launched just 18 months ago, indicating a growing interest in the intersection of science and compute.
A Bet on Deep-Tech Companies
Zavian Dar, Adam Goulburn, and Nan Li, the founding partners of Dimension Capital, made a bold prediction four years ago when they launched the firm. They believed that founders would increasingly want to build deep-tech companies that combined the boundaries of biotech and software. Now, the three partners admit to being impressed by how quickly their thesis has played out.
Notable Investments and Success Stories
The firm has made several notable investments, including a $30 million seed investment in Chai Discovery, a startup developing open-source AI foundation models for drug development. Last week, Chai Discovery announced that it raised $400 million at a $3.8 billion valuation. Dimension Capital also backed anti-aging startup New Limit at its Series A round in January 2025. Earlier this month, New Limit, co-founded by Coinbase CEO Brian Armstrong, completed a Series C at a $3.1 billion valuation.
Other Notable Investments and Acquisitions
Dimension Capital’s other notable investments include inference company Modal Labs and Anthropic. The firm received shares in the AI giant after Anthropic acquired its portfolio company, Coefficient Bio, a drug discovery platform, this spring for a reported $400 million.
Dimension Capital’s impressive fundraise and successful investments demonstrate the growing interest in the intersection of science and compute. As the tech industry continues to evolve, it will be exciting to see how Dimension Capital and other firms like it shape the future of deep-tech companies.
A Growing Interest in Science and Compute
The tech industry is witnessing a significant shift towards the intersection of science and compute. Dimension Capital’s $800 million fund is a testament to this growing interest. As more firms invest in deep-tech companies, we can expect to see innovative solutions and advancements in various fields, including biotech, software, and AI.
